This inventor holds 2 USPTO granted patents. Top assignees: Chiesi Farmaceutici S.p.a., Universita′ Degli Studi Di Milano. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 342 
2 out of 40 Years Active: 2024
Title: The Contributions of Inventor Matteo Cerea
Introduction
Matteo Cerea is an innovative inventor based in Milan, Italy, who has made significant contributions to the field of pharmaceuticals. With a focus on modifying drug release mechanisms, he has successfully patented two inventions that enhance the effectiveness of oral medications.
Latest Patents
Cerea's latest patents revolve around modified release pharmaceutical formulations comprising deferiprone. The first patent covers pharmaceutical compositions designed for oral administration in the form of tablets that allow for both twice-daily and once-daily intake. Additionally, he focuses on methods of producing and utilizing these tablets, emphasizing their convenience for patients. The second patent similarly addresses coated tablets with modified release properties, enabling safe and effective administration of deferiprone as either whole or half tablets.
Career Highlights
Matteo Cerea has built a commendable career in pharmaceutical research and development. He has worked with prestigious organizations, including Chiesi Farmaceutici S.p.A. and the Università Degli Studi di Milano. His time at these institutions has allowed him to refine his expertise in drug formulation and contribute to the advancement of medical treatments.
Collaborations
Throughout his career, Cerea has collaborated with notable colleagues such as Marisa Pertile and Andrea Gazzaniga. These partnerships have fostered a dynamic environment for innovative research, leading to the successful development of his patented formulations and furthering advances in pharmaceutical sciences.
Conclusion
Matteo Cerea stands out as a prominent inventor in the realm of pharmaceuticals, with his innovative work on modified release formulations showcasing the potential for improved patient care. His patents represent a significant leap forward in drug delivery systems, making a positive impact on the pharmaceutical industry and enhancing the lives of patients receiving deferiprone-based treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile